Physician Data Query

Last uploaded: August 28, 2024
Preferred Name

valsartan
Synonyms

N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine

CGP 48933

Diovan

L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-

Definitions

An orally active nonpeptide triazole-derived antagonist of angiotensin (AT) II with antihypertensive properties. Valsartan selectively and competitively blocks the binding of angiotensin II to the AT1 subtype receptor in vascular smooth muscle and the adrenal gland, preventing AT II-mediated vasoconstriction, aldosterone synthesis and secretion, and renal reabsorption of sodium, and resulting in vasodilation, increased excretion of sodium and water, a reduction in plasma volume, and a reduction in blood pressure. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47781" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47781" NCI Thesaurus)

ID

http://purl.bioontology.org/ontology/PDQ/CDR0000464172

altLabel

N-(p-(o-1H-Tetrazol-5-ylphenyl)benzyl)-N-valeryl-L-valine

CGP 48933

Diovan

L-Valine, N-(1-oxopentyl)-N-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-

CAS Registry

137862-53-4

cui

C0719949

C0216784

C0527644

DATE FIRST PUBLISHED

2006-01-25

Date last modified

2006-06-30

definition

An orally active nonpeptide triazole-derived antagonist of angiotensin (AT) II with antihypertensive properties. Valsartan selectively and competitively blocks the binding of angiotensin II to the AT1 subtype receptor in vascular smooth muscle and the adrenal gland, preventing AT II-mediated vasoconstriction, aldosterone synthesis and secretion, and renal reabsorption of sodium, and resulting in vasodilation, increased excretion of sodium and water, a reduction in plasma volume, and a reduction in blood pressure. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C47781" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C47781" NCI Thesaurus)

LT

TRD

NCI ID

C47781

notation

CDR0000464172

ORIG STY

Drug/agent

prefLabel

valsartan

tui

T109

T121

Delete Subject Author Type Created
No notes to display
Create mapping

Delete Mapping To Ontology Source
http://purl.bioontology.org/ontology/RXNORM/216652 RXNORM CUI
http://purl.bioontology.org/ontology/SNOMEDCT/386876001 SNOMEDCT CUI
http://purl.bioontology.org/ontology/MESH/D000068756 MESH CUI
http://purl.bioontology.org/ontology/MESH/D000068756 MESH CUI
http://purl.bioontology.org/ontology/RCD/x03xa RCD CUI
http://purl.bioontology.org/ontology/LNC/LP171649-9 LOINC CUI
http://purl.bioontology.org/ontology/NDDF/006279 NDDF CUI
http://purl.bioontology.org/ontology/VANDF/4020986 VANDF CUI
http://purl.bioontology.org/ontology/SCTSPA/108581009 SCTSPA CUI
http://purl.bioontology.org/ontology/RXNORM/69749 RXNORM CUI
http://purl.bioontology.org/ontology/NDFRT/N0000148456 NDFRT CUI
http://purl.bioontology.org/ontology/SNOMEDCT/108581009 SNOMEDCT CUI
http://purl.bioontology.org/ontology/MESH/D000068756 MESH CUI
http://purl.bioontology.org/ontology/SCTSPA/386876001 SCTSPA CUI
http://purl.bioontology.org/ontology/NDFRT/N0000006659 NDFRT CUI
http://purl.bioontology.org/ontology/ATC/C09CA03 ATC CUI
http://purl.bioontology.org/ontology/RCD/bk4.. RCD CUI
http://purl.bioontology.org/ontology/MSHFRE/D000068756 MSHFRE CUI
http://purl.bioontology.org/ontology/MSHFRE/D000068756 MSHFRE CUI
http://purl.obolibrary.org/obo/XCO_0001259 XCO LOOM
https://go.drugbank.com/drugs/DB00177 MDM LOOM
http://purl.bioontology.org/ontology/SNOMEDCT/386876001 SNOMEDCT LOOM
http://bmi.utah.edu/ontologies/hfontology/C0216784 HFO LOOM
http://www.phoc.org.cn/pmo/class/PMO_00018234 PMAPP-PMO LOOM
http://purl.bioontology.org/ontology/LNC/LP171649-9 LOINC LOOM
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C47781 NCIT LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 DRON LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 PDRO LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 CCONT LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 DINTO LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 EFO LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 BERO LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 DDSS LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 BIOMODELS LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 CHEBI LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 NIFSTD LOOM
http://purl.obolibrary.org/obo/CHEBI_9927 ECTO LOOM
http://www.semanticweb.org/admin/ontologies/2022/7/MIO:02630 MIO LOOM
http://evs.nci.nih.gov/ftp1/NDF-RT/NDF-RT.owl#N0000148456 OCVDAE LOOM
http://purl.bioontology.org/ontology/NDDF/006279 NDDF LOOM
http://purl.bioontology.org/ontology/VANDF/4020986 VANDF LOOM
http://www.drugbank.ca/drugs/DB00177 FTC LOOM
http://purl.obolibrary.org/obo/OMIT_0001319 OMIT LOOM
http://purl.bioontology.org/ontology/RXNORM/69749 NLMVS LOOM
http://purl.bioontology.org/ontology/RXNORM/69749 RXNORM LOOM
http://purl.bioontology.org/ontology/NDFRT/N0000148456 NDFRT LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#C0216784 OCHV LOOM
http://sbmi.uth.tmc.edu/ontology/ochv#21148 OCHV LOOM
http://purl.obolibrary.org/obo/MESH_D000068756 BERO LOOM
http://purl.obolibrary.org/obo/NCIT_C47781 BERO LOOM
http://purl.bioontology.org/ontology/MESH/D000068756 MESH LOOM
http://phenomebrowser.net/ontologies/mesh/mesh.owl#C081489 RH-MESH LOOM
http://purl.bioontology.org/ontology/ATC/C09CA03 ATC LOOM
http://purl.jp/bio/4/id/200906040213256090 IOBC LOOM
http://purl.bioontology.org/ontology/RCD/bk4.. RCD LOOM
http://www.co-ode.org/ontologies/galen#Valsartan GALEN LOOM